We present a clinical case report regarding recurrent atrial fibrillation in a patient with ulcerative colitis treated with azathioprine. Atrial fibrillation represents the most common sustained cardiac arrhythmia, occurring in 1–2% of the general population and characterized by seemingly disorganized atrial depolarizations without effective atrial contraction. Several mechanisms determine this arrhythmia; in particular remodelling (structural, mechanical and electrical alteration related to atrial fibrillation). The pro-arrhythmic effect of azathioprine may be evaluated during immunosuppressive therapy to be aware of this serious but reversible adverse effect.
CassinottiAMassariAFerraraEGrecoSBosaniMArdizzoneSBianchi PorroG. New onset of atrial fibrillation after introduction of azathioprine in ulcerative colitis: case report and review of the literature. Eur J Clin Pharmacol2007; 63:875–8.
2.
MurphyGFultonRAKeeganDAJ. Fast atrial fibrillation induced by azathioprine. Br Med J1985; 291:1049.
3.
StewartSHartCLHoleDJMcMurrayJJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart2001;86:516–21.
4.
AllessieMABoydenPCammAJ. Pathophysiology and prevention of atrial fibrillation. Circulation2001; 103:769–77.
5.
ZipesDP. Atrial fibrillation. A tachycardia-induced cardiomyopathy. Circulation1997; 95:562–564.
6.
YadavPKLiuZ. Current strategies for the treatment of ulcerative colitis. Recent Pat Inflamm Allergy Drug Discov2009; 3:65–72.
7.
Brazilian Study Group of Inflammatory Bowel Diseases. Consensus guidelines for the management of inflammatory bowel disease. Arq Gastroenterol2010;47:313–25.
